WuXi AppTec Acquires Drug Discovery Firm Crelux
WuXi AppTec, a contract provider of drug discovery and development services, has acquired Crelux GmbH, a provider of discovery leading drugs based on structure based in Munich, Germany. The move positions the Shanghai-headquartered WuXi AppTec in Europe.
Crelux was founded in 2005 and has its laboratories in the Innovation Center for Biotechnology (IZB) in Martinsried, near Munich, Germany. Crelux offers a range of services to support the discovery process, conformational analysis and optimization, including protein production, biophysical studies and X-ray crystallography.
Source: WuXi AppTech